Antivirals - GEN - Genetic Engineering and Biotechnology News

Immuno-oncology

StockWatch: Checkmate Shares Quadruple on Regeneron Buyout

Infectious Diseases

Pfizer to Acquire ReViral for Up to $525M, Expanding RSV Pipeline

Antivirals

Nasal Spray for Prevention/Early Treatment of COVID-19 Works in Mice

coronavirus

Antivirals

COVID-19 Proteases Inhibited by Repurposed FDA-Approved Drugs

Unemployed businesswoman depressed sitting on a path due to company bankrupted while coronavirus spreading situation

Antivirals

Keeping SARS-CoV-2 Reinfections at Bay

Coronavirus

“Game Changer:” After Vaccines, Pfizer Stakes Claim in COVID-19 Drugs, Too

Dengue virus, artwork

Antivirals

Potent Dengue Antiviral Effective against All Known Variants

Antivirals

Pardes Biosciences Advances Oral Antiviral Drug for SARS-CoV-2 Infections

Antivirals

Merck to Seek FDA EUA for COVID-19 Pill after Positive Phase...

Scanning electron micrograph of HIV particles infecting a human T cell. By binding to two unchanging sites on the surface of HIV

Antivirals

Gene Identified in Mice and Monkeys Acts as Natural Antiviral Against...

Aseptic virus laboratory

Antivirals

VirusMED Database Offered to Speed Development of Antiviral Drugs and Vaccines

Coronavirus COVID-19

Antivirals

SARS-CoV-2-Blocking Nanobodies Can Handle Mutations, Take the Heat

Virus

Antivirals

Mammalian Stem Cells Harness Same Antiviral Defense Mechanism as Do Plants...

Coronavirus COVID-19

Antivirals

SARS-CoV-2 Variants May Succumb to Multivalent Nanobodies

Antivirals

COVID-19 Antiviral Candidate Hobbles RNA Replicase

12 3...9 Page 1 of 9